Breaking News, Promotions & Moves

Biopharmaceutical Company ReAlta Hires New CEO, R&D Head

Names David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer.

Author Image

By: Charlie Sternberg

Associate Editor

ReAlta Life Sciences Inc., a clinical-stage biopharmaceutical company dedicated to addressing rare and acute inflammatory diseases, has tapped two biopharmaceutical veterans to lead the company: David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer.   “As ReAlta evolves into a late-stage development company with multiple clinical programs spanning three distinct therapeutic areas with significant unmet need, I am confident that David and Pao...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters